| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/22/2013 | WO2013090633A3 Composition and method for the diagnosis and treatment of iron-related disorders |
| 08/22/2013 | WO2013078170A8 Purification of anti-c-met antibodies |
| 08/22/2013 | WO2013064830A3 Medical use |
| 08/22/2013 | WO2013028330A3 Methods of reducing level of one of more impurities in a sample during protein purification |
| 08/22/2013 | US20130217865 Tumor Specific Antibody |
| 08/22/2013 | US20130217864 Human interleukin-1 receptor antagonist - hybrid fc fusion protein |
| 08/22/2013 | US20130217862 Antibody modulators of hepatocyte growth factor activator |
| 08/22/2013 | US20130217861 Methods for expression and purification of immunotoxins |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217612 Complete genome sequence of the methanogen methanobrevibacter ruminantium |
| 08/22/2013 | US20130217145 Antibodies which detect pivkaii and methods of use thereof |
| 08/22/2013 | US20130216576 Pneumococcal serotype 6d |
| 08/22/2013 | US20130216566 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 08/22/2013 | US20130216555 Method of providing disease-specific binding molecules and targets |
| 08/22/2013 | US20130216549 Anti-IP-10 Antibodies and Uses Thereof |
| 08/22/2013 | US20130216548 Monoclonal antibodies against c-met |
| 08/22/2013 | US20130216547 Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof |
| 08/22/2013 | US20130216546 Methods of Treating Glucose Metabolism Disorders |
| 08/22/2013 | US20130216545 Early Diagnosis and Novel Treatment of Cancer |
| 08/22/2013 | US20130216544 Anti-La antibodies and their use for immunotargeting |
| 08/22/2013 | US20130216543 Antibody-based constructs directed against tyrosine kinase receptors |
| 08/22/2013 | US20130216542 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 08/22/2013 | US20130216541 Stable subcutaneous protein formulations and uses thereof |
| 08/22/2013 | US20130216538 Compositions and Methods for Treating Inflammatory Disorders |
| 08/22/2013 | US20130216535 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 08/22/2013 | US20130216534 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
| 08/22/2013 | US20130216529 Humaneered anti-factor b antibody |
| 08/22/2013 | US20130216528 Anti-GD2 Antibodies |
| 08/22/2013 | US20130216496 Methods for treating tweak-related conditions |
| 08/21/2013 | EP2628753A1 Humanized anti-human NKG2A monoclonal antibody |
| 08/21/2013 | EP2628752A1 Engineered anti-TSLP antibody |
| 08/21/2013 | EP2628751A2 Binding members for interleukin-6 and use thereof |
| 08/21/2013 | EP2628750A2 Targeted identification of immunogenic peptides |
| 08/21/2013 | EP2628486A2 Method for treating bone fracture with anti-sclerostin antibodies |
| 08/21/2013 | EP2627773A1 Restricted immunoglobulin heavy chain mice |
| 08/21/2013 | EP2627673A1 Therapies for improving pulmonary function |
| 08/21/2013 | EP2627672A1 Human anti-tau antibodies |
| 08/21/2013 | EP2627671A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
| 08/21/2013 | EP2627357A2 Antibodies that bind amyloid oligomers |
| 08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2013 | CN103261893A Neoantibodies for diagnosing tissue injury |
| 08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
| 08/21/2013 | CN103261230A Anti-PCSK9 antibodies and methods of use |
| 08/21/2013 | CN103261229A Combination therapy of an afucosylated CD20 antibody with a MDM2 inhibitor |
| 08/21/2013 | CN103261228A Human antibodies to human TNF-like ligand 1A (TL1A) |
| 08/21/2013 | CN103261227A CD33 binding agents |
| 08/21/2013 | CN103261226A Anti-cd48 antibodies and uses thereof |
| 08/21/2013 | CN103261225A Anti-desupr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery |
| 08/21/2013 | CN103261224A Methods and compositions for liver cancer therapy |
| 08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
| 08/21/2013 | CN103261222A Novel antibody derivatives |
| 08/21/2013 | CN103261221A Immunological cofilin-1 protein measurement method |
| 08/21/2013 | CN103261220A Methods for the generation of multispecific and multivalent antibodies |
| 08/21/2013 | CN103260646A Notum protein modulators and methods of use |
| 08/21/2013 | CN103260639A Dual variable domain immunoglobulins and uses thereof |
| 08/21/2013 | CN103255138A Preparation method of HIV-1 receptor binding epitope recognizing soluble single chain antibody |
| 08/21/2013 | CN103255128A Methods for preparing monoclonal antibody and hybridoma cell strain thereof by multiple antigens in immune high-flux manner |
| 08/21/2013 | CN103255109A Hybridoma cell strain AFG1G6, its monoclonal antibody and aflatoxin G1 immunochromatographic test strip |
| 08/21/2013 | CN103255108A Cell adhesion molecule 5 monoclonal antibody, preparation method and applications thereof |
| 08/21/2013 | CN103254312A Mouse?monoclonal?antibody and its?preparation?method?and?application thereof |
| 08/21/2013 | CN103254311A Method for preparing antibody-maytansine alkaloid medicine conjugate |
| 08/21/2013 | CN103254310A Improved antibody molecules |
| 08/21/2013 | CN103254309A Improved nanobodies TM against tumor necrosis factor-alpha |
| 08/21/2013 | CN103254308A Monoclonal antibody of haemagglutinin protein of H5 subtype of avian influenza virus, or binding activity segment thereof and application of monoclonal antibody or binding activity segment |
| 08/21/2013 | CN103254307A HPV18E7 monoclonal antibody, hybridoma cell strain and application |
| 08/21/2013 | CN103254294A CD34-SG17 polypeptide fragment as well as preparation method and application thereof |
| 08/21/2013 | CN103251952A Genetic products differentially expressed in tumors and use thereof |
| 08/21/2013 | CN103251948A Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 08/21/2013 | CN103251947A Scfv antibodies which pass epithelial and/or endothelial layers |
| 08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 08/21/2013 | CN102653558B Single-chain antibody and application thereof in detecting aflatoxin |
| 08/21/2013 | CN102504020B Polypeptide capable of inducing antibody against chicken beta2-microglobulin and use thereof |
| 08/21/2013 | CN102216452B Cell lines and proteins with variant glycosylation pattern |
| 08/21/2013 | CN101975857B Virus disaggregating agent and method for disaggregating virus antigen-antibody complex and detecting HCV (Hepatitis C Virus) antigen |
| 08/21/2013 | CN101970670B Methods for inhibiting angiogenesis using egfl8 antagonists |
| 08/21/2013 | CN101724020B Immunological contraception target universal for mammals and specific antibody thereof |
| 08/21/2013 | CN101668771B Sequence based engineering and optimization of single chain antibodies |
| 08/21/2013 | CN101616935B Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 08/21/2013 | CN101573382B Monoclonal antibodies and directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 08/21/2013 | CN101019024B Taxol immunoassay method |
| 08/20/2013 | US8513391 Monoclonal antibodies for Ebola and Marburg viruses |
| 08/20/2013 | US8513390 Modified antibody compositions, methods of making and using thereof |
| 08/20/2013 | US8513389 Engineered anti-IL-23p19 antibodies |
| 08/20/2013 | US8513388 Anti-Notch3 antibodies |
| 08/20/2013 | US8513387 Methods and compositions for detecting amyotrophic lateral sclerosis |
| 08/20/2013 | US8513184 Macrocyclic inhibitors of flaviviridae viruses |
| 08/20/2013 | US8513164 Protein (poly)peptides libraries |
| 08/20/2013 | US8513028 Use of MLN51 gene and protein |
| 08/20/2013 | US8512959 Monoclonal antibody based biomarker discovery and development platform |
| 08/20/2013 | US8512952 Estrogen receptors and methods of use |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/20/2013 | US8512706 Compositions of F(ab′)2 antibody fragments |
| 08/20/2013 | US8512704 Tmem27 antibody |
| 08/20/2013 | US8512702 Prostate cancer diagnosis and treatment |
| 08/20/2013 | US8512699 Anti-VEGF antibodies |
| 08/20/2013 | CA2669800C Nerve elongation promoter and elongation inhibitor |
| 08/20/2013 | CA2508660C Antibodies against pd-1 and uses therefor |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2477794C System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 08/20/2013 | CA2445349C Anti-cd40 monoclonal antibody |